1372452-41-9 Usage
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
(R)-3-(1-hydroxyethyl)benzenesulfonamide is used as a building block for the synthesis of pharmaceuticals and agrochemicals. Its versatile chemical reactivity allows for the creation of a wide range of compounds with potential therapeutic and pesticidal properties.
Used in Material Science:
In the field of material science, (R)-3-(1-hydroxyethyl)benzenesulfonamide has potential applications due to its unique chemical properties. It can be utilized in the development of new materials with specific characteristics, such as improved stability or reactivity.
Used as a Ligand in Organometallic Chemistry:
(R)-3-(1-hydroxyethyl)benzenesulfonamide can also be used as a ligand in organometallic chemistry. Its stereochemistry and reactivity make it a valuable component in the design and synthesis of organometallic complexes with potential applications in catalysis and other chemical processes.
Used in Medical Research:
(R)-3-(1-hydroxyethyl)benzenesulfonamide is being investigated for its potential use in the treatment of various medical conditions. Its potential biological activities and chemical properties make it a promising candidate for further research and development in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 1372452-41-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,2,4,5 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1372452-41:
(9*1)+(8*3)+(7*7)+(6*2)+(5*4)+(4*5)+(3*2)+(2*4)+(1*1)=149
149 % 10 = 9
So 1372452-41-9 is a valid CAS Registry Number.
1372452-41-9Relevant academic research and scientific papers
Preparative access to medicinal chemistry related chiral alcohols using carbonyl reductase technology
Rowan, Andrew S.,Moody, Thomas S.,Howard, Roger M.,Underwood, Toby J.,Miskelly, Iain R.,He, Yanan,Wang, Bo
, p. 1369 - 1381 (2013/12/04)
Libraries of highly enantioenriched secondary alcohols in both enantiomeric forms were synthesised by enzymatic reduction of their parent ketones using selectAZyme carbonyl reductase (CRED) technology. Commercially available CREDs were able to reduce a range of substrate classes efficiently and with very high enantioselectivity. Matching substrate classes to small subsets of CREDs enabled the fast development of preparative bioreductions and the rapid generation of 100-1500 mg samples of chiral alcohols in typically >95% ee and the majority in ≥99.0% ee. The conditions for small scale synthesis were then scaled up to 0.5 kg to deliver one of the chiral alcohols, (S)-1-(4-bromophenyl)-2-chloroethanol, in 99.8% ee and 91% isolated yield.
